SARS -CoV-2 T-cell immunity to variants of concern following vaccination

Recently, two mRNA vaccines to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become available, but there is also an emergence of SARS-CoV-2 variants with increased transmissibility and virulence(1–6). A major concern is whether the available vaccines will be equally effective aga...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallagher, Kathleen M.E., Leick, Mark B., Larson, Rebecca C., Berger, Trisha R., Katsis, Katelin, Yam, Jennifer Y., Brini, Gabrielle, Grauwet, Korneel, Maus, Marcela V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109204/
https://www.ncbi.nlm.nih.gov/pubmed/33972942
http://dx.doi.org/10.1101/2021.05.03.442455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109204/
https://www.ncbi.nlm.nih.gov/pubmed/33972942
http://dx.doi.org/10.1101/2021.05.03.442455

Ejemplares similares